Showing 1 posts of 1 posts found.


Amgen and Cytokinetics’ drug falls short in heart failure despite hitting primary goal

October 9, 2020
Medical Communications Amgen, cytokines, heart failure, pharma

New Phase 3 data has come to light on Amgen and Cytokinetics’ cardiac myosin activator therapy omecamtiv mecarbil fell short …

Latest content